Skip to main content
. 2021 Jun 1;13:4403–4416. doi: 10.2147/CMAR.S307517

Figure 1.

Figure 1

Study design flowchart. A total of 302 patients with ameloblastoma with complete relevant information were enrolled in this study and then randomly separated into training and validation sets with a ratio of 7:3.